In addition, 120-day administration of 20 IU or 40 IU insulin in 104 participants showed that both doses improved performance on the Alzheimer’s Disease Assessment Scale-Cognitive subscale (ADAS-Cog12), a measure of global cognition [169]. The gene discussed is INS; the disease is early-onset autosomal dominant Alzheimer disease.